Literature DB >> 15107633

Associations among human leukocyte antigen (HLA) class II DQ variants, bacterial sexually transmitted diseases, endometritis, and fertility among women with clinical pelvic inflammatory disease.

Roberta B Ness1, Robert C Brunham, Caixia Shen, Debra C Bass.   

Abstract

BACKGROUND: We investigated associations between HLA class II DQ alleles, chlamydial and gonococcal cervicitis, endometritis, and infertility among women with pelvic inflammatory disease (PID).
METHODS: Ninety-two women with clinical signs and symptoms of mild-to-moderate PID, enrolled in the PEACH Study, were evaluated. For all HLA class II DQ alleles with a prevalence of 10% or greater in the population, we assessed demographics, cervical infections, endometrial pathology, and fertility outcomes.
RESULTS: Chlamydial cervicitis, gonococcal cervicitis, endometritis, and infertility were all more common among women carrying the DQA *0301 allele after adjustment for race. Endometritis and infertility were somewhat less common (or pregnancy more common) among women carrying the DQA *0501 and DQB *0402 alleles.
CONCLUSION: Among women with signs and symptoms of PID, carriage of the DQA *0301, DQA *0501, and DQB *0402 alleles altered the occurrence of lower genital tract infection, upper genital tract inflammation, and infertility.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15107633     DOI: 10.1097/01.olq.0000123649.52033.75

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  9 in total

Review 1.  Inflammation in reproductive disorders.

Authors:  Gerson Weiss; Laura T Goldsmith; Robert N Taylor; Dominique Bellet; Hugh S Taylor
Journal:  Reprod Sci       Date:  2009-02       Impact factor: 3.060

2.  Mapping immunodominant antigens and H-2-linked antibody responses in mice urogenitally infected with Chlamydia muridarum.

Authors:  Hao Zeng; Shuping Hou; Siqi Gong; Xiaohua Dong; Quanming Zou; Guangming Zhong
Journal:  Microbes Infect       Date:  2012-03-03       Impact factor: 2.700

3.  Semen quality is affected by HLA class I alleles together with sexually transmitted diseases.

Authors:  P I Marques; J C Gonçalves; C Monteiro; B Cavadas; L Nagirnaja; N Barros; A Barros; F Carvalho; A M Lopes; S Seixas
Journal:  Andrology       Date:  2019-04-19       Impact factor: 3.842

4.  Human leukocyte antigen (HLA)-B, DRB1, and DQB1 allotypes associated with disease and protection of trachoma endemic villagers.

Authors:  Muneer Abbas; Linda D Bobo; Yu-Hsiang Hsieh; Noureddine Berka; Georgia Dunston; George E Bonney; Victor Apprey; Thomas C Quinn; Sheila K West
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-29       Impact factor: 4.799

5.  Immunogenetic correlates of Neisseria gonorrhoeae infection in adolescents.

Authors:  William M Geisler; Chengbin Wang; Jianming Tang; Craig M Wilson; Peggy A Crowley-Nowick; Richard A Kaslow
Journal:  Sex Transm Dis       Date:  2008-07       Impact factor: 2.830

6.  Identification of MHCII variants associated with chlamydial disease in the koala (Phascolarctos cinereus).

Authors:  Quintin Lau; Joanna E Griffith; Damien P Higgins
Journal:  PeerJ       Date:  2014-06-19       Impact factor: 2.984

7.  Comparing the Frequency of Endometritis in Unexplained Infertility and Anovulatory Infertility.

Authors:  Ataollah Ghahiri; Bahare Malekzadeh; Hatav Ghassemi Tehrani
Journal:  Adv Biomed Res       Date:  2017-11-30

8.  Identifying HLA DRB1-DQB1 alleles associated with Chlamydia trachomatis infection and in silico prediction of potentially-related peptides.

Authors:  Leidy Pedraza; Milena Camargo; Darwin A Moreno-Pérez; Ricardo Sánchez; Luisa Del Río-Ospina; Indira M Báez-Murcia; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.379

9.  HLA-DQB1*06 is a risk marker for chlamydia reinfection in African American women.

Authors:  Kristin M Olson; Jianming Tang; LaDraka' Brown; Christen G Press; William M Geisler
Journal:  Genes Immun       Date:  2018-02-26       Impact factor: 2.676

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.